DMK Pharmaceuticals Corp DMKPQ
$0.00
Last Updated: Nov 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
DMKPQ Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, DMK Pharmaceuticals Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
DMK Pharmaceuticals Corp. Stock Analysis DMKPQ
United States Health Care Nano Cap DMK Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. The firm is focused on developing and commercializing products for the treatment of opioid overdose and substance-use disorders. Its ZIMHI (naloxone) is FDA approved for the treatment of opioid overdose. The company is focused on developing novel therapies for opioid use disorder (OUD) and other important neuro-based conditions where patients are currently underserved. Its technologies are at the forefront of endorphin-inspired drug design with its mono, bi-, and tri-functional small molecules that simultaneously modulate critical networks in the nervous system. The company has a library of approximately 750 small molecule neuropeptide analogues and a differentiated pipeline. The Company’s lead clinical-stage product candidate, DPI-125, is being studied as a treatment for OUD. Its other development stage product candidates include DPI-221 for bladder control problems and DPI-289 for severe end stage Parkinson’s disease.
DMK Pharmaceuticals Corp (DMKPQ) Chart
Financial Metrics & Statements of DMK Pharmaceuticals Corp (DMKPQ)
FAQ's for DMK Pharmaceuticals Corp (DMKPQ)
- As of August 2026, DMK Pharmaceuticals Corp DMKPQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes DMK Pharmaceuticals Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in DMK Pharmaceuticals Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of DMK Pharmaceuticals Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of DMK Pharmaceuticals Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of DMK Pharmaceuticals Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for DMK Pharmaceuticals Corp (DMKPQ)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
